The invention relates to building of an SV40LT
antigen gene-mediated klinefelter syndrome
cell model and a
cell bank of the klinefelter syndrome
cell model, applied to the field of
medical research. The building method is mainly characterized by comprising the following processes: building an SV40LTag-pcDNA3.1(1) recombinant by using T4
DNA ligase,
BamHI, pcDNA3.1(1)
DNA and SV40LTag
DNA according to a conventional method; purifying the recombinant by using competent
escherichia coli, introducing the recombinant into an
in vitro passage cell which is digested by
collagenase II, or klinefelter syndrome histocyte which is in
logarithmic growth, and integrating the recombinant with DNA; carrying out enlarging cultivation, screening cells containing positive recombinants by G418, and
cloning; and screening a cell of which the
cell morphology, the
growth curve,
karyotype,
soft agar colony growth, nude mice tumor experiment result and
transfection cell SV40 big T
gene detection result, mRNA product measuring result and
DNA sequencing result are in fit with the characteristics of an immortalized cell and are the same as or similar to that of a
primary cell to be taken as an
in vitro research
cell model for the SV40LT-mediated klinefelter syndrome; and a foundation is laid for
in vitro long-term research of
pathogenesis of the klinefelter syndrome from the
cellular level.